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Insulin-resistant subjects develop more severe and diffuse coronary artery atherosclerosis
than insulin-sensitive controls but the mechanisms that mediate this atherosclerosis pheno-
type are unknown.
Research Objective
To determine the metabolic parameters that associate with the severity of coronary athero-
sclerosis in insulin resistant pigs fed a high fat/high NaCl diet.
Key Methods
The primary endpoint was severity of coronary atherosclerosis in adult pigs (Sus scrofa, n
= 37) fed a high fat diet that also contained high NaCl (56% above recommended levels)
for 1 year.
Principal Findings
Twenty pigs developed severe and diffuse distal coronary artery atherosclerosis (i.e., severe
= intimal area as a percent medial area > 200% in at least 2 coronary artery cross sections
and diffuse distal = intimal area as a percent medial area 150% over 3 sections separated
by 2 cm in the distal half of the coronary artery). The other 17 pigs had substantially less cor-
onary artery atherosclerosis. All 37 pigs had blood pressure in a range that would be consid-
ered hypertensive in humans and developed elevations in total and LDL and HDL
cholesterol, weight gain, increased backfat, and increased insulin resistance (Bergman Si)
without overt diabetes. Insulin resistance was not associated with atherosclerosis severity.
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Five additional pigs fed regular pig chow also developed increased insulin resistance but
essentially no change in the other variables and little to no detectible coronary atherosclero-
sis. Most importantly, the 20 high fat/high NaCl diet -fed pigs with severe and diffuse distal
coronary artery atherosclerosis had substantially greater increases (p< 0.05) in oxidized LDL
(oxLDL) and fructosamine consistent with increased protein glycation.
Conclusion
In pigs fed a high fat/high NaCl diet, glycated proteins are induced in the absence of overt
diabetes and this degree of increase is associated with the development of severe and dif-
fuse distal coronary artery atherosclerosis.
Introduction
The increasing prevalence of insulin resistance and type 2 diabetes is likely to be attended by a
substantial increase in cardiovascular disease (CVD).[1–3] Insulin resistance (IR) is defined as
a decreased biological response to normal concentrations of serum insulin that over time leads
to compensatory hyperinsulinemia.[2] Insulin resistant and diabetic humans often develop
multiple and severe coronary atherosclerotic lesions that are diffuse in that they involve long
arterial segments especially in the distal portions of the coronary arteries.[4–8] In addition,
there is more extensive remodeling and fibrous caps are thicker.[5, 7] The resulting small cali-
ber arteries are less amenable to angioplasty, stent placement, surgical reconstruction or
bypass.[9] Even when coronary artery stent placement or bypass surgery is feasible, often dis-
ease progression outside of the stented segment of the coronary artery or bypass insertion site
limits the duration of benefit in patients with IR and diabetes.[10] Remarkably, even the most
aggressive medical treatment regimens do not lower the risk for CVD to the non-diabetic level.
[9, 11–15] These findings strongly suggest that factors other than absolute glucose concentra-
tions may be activating pathophysiological mechanisms that augment the development of ath-
erosclerosis. Thus, there is a need for a relevant animal model of insulin resistance and/or type
2 diabetes that also exhibits severe and diffuse coronary and aortic atherosclerosis which are
associated with identifiable biochemical abnormalities.
Our objective was to investigate whether the severity of atherosclerosis is associated not
only with lipoprotein concentrations, weight, blood pressure, biomarkers of inflammation and
IR in an animal model but also changes in parameters that measure protein glycation. Our
experimental approach was to study normocholesterolemic pigs fed a high fat diet that also
contained increased NaCl. Our choice of pigs was driven by the fact that, like humans, they
develop coronary artery and aortic atherosclerosis and insulin resistance. In addition, pigs have
been used in many studies to define the mechanisms that mediate increased atherosclerosis in
diabetes.[16–18] Our results show that the experimental pigs developed varying degrees of cor-
onary atherosclerosis that were grouped as either severe and diffuse distal ormoderate. Athero-
sclerosis severity was not associated with increases in body weight, backfat, insulin or glucose
levels, insulin resistance, blood pressure, or biomarkers of inflammation. Two other variables,
however, that have been associated with increased oxidative protein glycation, oxLDL and fruc-
tosamine, were found to be substantially higher in animals with the severe and diffuse distal
coronary atherosclerosis phenotype as compared to animals with moderate disease. Thus,
although our data are associational and not mechanistic, this paradigm suggests that the
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increased protein glycation that occurs with feeding a high fat/high NaCl diet may enhance the
severity of atherosclerosis development in insulin resistant, hypercholesterolemic pigs.
Materials and Methods
Experimental Pigs
All pigs were produced and maintained in the same environmental conditions at the Francis
Owen Blood Research Laboratory at the University of North Carolina at Chapel Hill. The back-
ground was Spotted Poland/China and Yorkshire crosses. Male and female pigs from the fol-
lowing two genotypes were used: (1) normocholesterolemic or (2) heterozygous familial
hypercholesterolemic (FH) that have a recessive inheritance pattern.[19–21] Both genotypes of
pigs are normocholesterolemic at baseline and only exhibit hypercholesterolemia when fed a
high fat diet. In addition to being identified by normal cholesterol levels, FH heterozygotes are
also identified from litters produced by known sires and dams with normal LDL receptor
sequences or carrying the FH mutation, a missense mutation in a single base pair (C253➔ T253)
of the LDL receptor that results in an arginine94 to cysteine94 mutation, located in the region
that corresponds to exon 4 in the human ligand binding domain.[19–21] Pigs were maintained
in agricultural style Hog Slats Inc buildings with ambient light and dark cycles, free access to
water, with a temperature range of 55 to 85 degrees F. All pigs were checked daily for food con-
sumption and general health issues. The UNC Division of Laboratory Animal Medicine pro-
vided regular veterinarian oversight. Forty-two pigs were entered into the year long study as
they became available (Fig 1). Thirty-seven pigs were fed a high fat/high NaCL diet for one
year: 16 normal (10 males, 6 females) and 21 heterozygous FH (10 males, 11 females). Five pigs
were fed regular pig chow: 2 normal (1 male, 1 female) and 3 heterozygous FH (1 male, 2
females). The mean age at study entry was 3.2 ± 1.6 years.
Fig 1. Study Design. The 42 pigs entered into this study are listed according to the diet they were fed, genotype (NL = normal, FH het = FH heterozygous)
and gender.
doi:10.1371/journal.pone.0132302.g001
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Ethics Statement
All pigs were handled in strict accordance with the USDA regulations and the standards
described in the 2010 Guide for the Care and Use of Laboratory Animals 8th edition (http://
grants.nih.gov/grants/olaw/Guide-for-the-Care-and-Use-of-Laboratory-Animals.pdf). All pro-
cedures and protocols were in accordance with institutional guidelines and approved by the
Institutional Animal Care and Use Committee at the University of North Carolina in Chapel
Hill (Animal Subject Assurance #A3410-01). When necessary, ketamine and acepromazine
were given for sedation. See also PONE-D-15-01878R1 NC3Rs ARRIVE Guidelines Checklist
Final in S1 File.
High Fat/High NaCl Diet and Regular Pig Chow
The high fat /high NaCl diet consisted of pig chow (5NP8Wayne 15% Pig & Sow Pellets, Gran-
ville Milling, Granville NC) supplemented with 1% cholesterol, 20% beef tallow, and 0.75%
cholate by weight.[22, 23] The NaCl content of the diets was measured (Eurofins Scientific Inc,
Des Moines, IA) and 5NP8 provided 0.35% or 8 grams/day as recommended[24] and the high
fat diet provided 0.55% or 12.5 grams/day, a 56% increase. The total calories in the high fat/
high NaCl diet were distributed as: 43% fat, 12.5% protein, and 44.5% carbohydrate. The 5NP8
was fed to the 5 control pigs as the source of regular pig chow. All pigs were fed in the morning
once per day in their pen to be able to monitor and confirm food consumption.
Sampling Protocol during Year Long Study
Weight, backfat, blood pressure, total and LDL and HDL cholesterol, oxLDL, fructosamine,
aldosterone, triglycerides, Bergman Frequently Sampled Intravenous Glucose Tolerance Test
(FSIVGTT), and serum and plasma inflammatory markers (TNF-alpha, IL-6, PAI-1, CRP)
were obtained at baseline (BL), 3, 6, and 12 months of the year-long study. Serum glucose was
measured monthly while the pig was fully conscious in addition to when it was sedated for the
[25] FSIVGTT. Serum chemistry panels were obtained monthly to monitor general health sta-
tus and processed by a commercial veterinary laboratory (Antech, Cary NC). At study termina-
tion all pigs were euthanized with an overdose of pentobarbital (6 grains/10 lbs. iv.) and tissue
samples for morphometry were collected from all three coronary arteries and the abdominal
aorta.
Bergman Frequently Sampled Intravenous Glucose Tolerance Test
(FSIVGTT)
Each pig was sedated with ketamine 4–6 mg/kg intramuscular (IM) and acepromazine 0.1–0.3
mg/kg IM. Two intravenous catheters were placed, one for sampling and one for infusing glu-
cose and insulin. A bolus of glucose (0.3 gm/kg IV) was administered as a 50% solution over ~5
to 10 min. Serum was prepared from blood samples obtained at -15, -10, -5, -1, 2, 3, 4, 5, 6, 8,
10, 14, and 19 minutes to measure insulin and glucose concentrations. At 20 minutes, an insu-
lin bolus (0.03U/kg IV, Novolin R Human Insulin Regular, Novo Nordisk) was injected and
blood samples for insulin and glucose concentrations were collected at 22, 25, 30, 40, 50, 70,
100, 140, and 180 minutes. The data were analyzed by the Bergman method to calculate an
insulin sensitivity index (Si) using MINMODMillennium version 6.02.[26] This method has
been widely used to estimate insulin sensitivity in humans and pigs.[25, 27–32]
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Measurement of Body Weight, Backfat, and Arterial Blood Pressure
Pigs were weighed on a FlexWeigh scale (model LPF-4824) with a digital readout (Velcon/Flex-
Weigh Model 5). Backfat has been used as an index of total body fat in pigs[33–38] and was
measured by ultrasound over the last rib with the pig standing (Fukuda Denshi, model
UF750XT). The intra-animal variability was< 7%. Arterial blood pressure was measured in
the tail of conscious pigs (Veterinary Blood Pressure Monitor, model 9301V, CAS Medical Sys-
tems, Inc).[39–41] The results are the mean of 5 measurements taken over 5 min.
Total and LDL and HDL Cholesterol, Triglycerides, Insulin, and Glucose
Serum cholesterol was measured with the Cholesterol E kit (Wako, Richmond, VA) that uti-
lizes an enzymatic colorimetric method for quantitative determination of total cholesterol in
serum. LDL and HDL cholesterol were measured by colorimetric endpoint reactions using the
Liquid Direct LDL and HDL Cholesterol Kits, respectively (Amresco, Solon, OH). Reactions
were performed according to the manufacturer’s instructions modified for a 96 well plate and
optical density was read using a Vmax kinetic microtiter plate reader (Molecular Devices). Tri-
glycerides were measured by an enzymatic method using triglyceride reagent (Sigma Aldrich).
Serum insulin was measured by a solid phase RIA (ICN, lower unit of detection is 2 μU/ml).
The intraassay variability was 4% and the interassay variability was 6%. Serum glucose was
measured with a 2300 STAT PLUS (YSI, Yellow Springs, Ohio).
Inflammatory Markers, oxLDL, Fructosamine, and Aldosterone
Pig specific ELISAs were used according to the manufacturer’s instructions to measure TNF-
alpha (Biosource),[42] IL-6 (R&D Systems), PAI-1 (Molecular Innovations, Southfield, MI),
[43] CRP (Pig CRP, Tri-Delta Diagnostics), and oxLDL (Mercodia, Uppsala, Sweden).[44–46]
Fructosamine was measured in serum by a colorimetric endpoint reaction according to the
manufacturer’s instructions (Raichem, San Diego, CA). Aldosterone was measured by enzyme
immunoassay with a commercially available kit (Aldosterone EIA, Alpco Diagnostics, Salem,
NH) using serum samples that were ether extracted, dried and reconstituted in sample buffer.
Morphometry of Coronary and Abdominal Aortic Atherosclerosis
Coronary artery and aortic atherosclerosis were measured as previously described.[23, 47] Digi-
tal, calibrated images of all coronary and aortic sections were made by scanning the histological
sections using the Aperio ScanScope and these images were measured using Aperio ImageScope
software. Coronary artery atherosclerosis histomorphometry measurements include medial
area, intimal area, percent stenosis and intimal area as percent medial area.[23, 47] Abdominal
aortic atherosclerosis measurements include histomorphometry (i.e., medial area, intimal area,
and intimal area as percent medial area) as well as en face morphometry measurements of the
total area, lesion area and percent surface area with raised lesions.[23, 47] Coronary and aortic
atherosclerosis was measured by at least two blinded observers using the samemicroscope, com-
puter, and software. The inter- and intra- observer variability was between 4 and 7%.
Definition of Severe and Diffuse Distal Coronary Artery Atherosclerosis
Severe coronary atherosclerosis was defined as mean intimal area as a percent of medial area
of 200% in at least two coronary artery cross sections in the proximal or distal half. Diffuse
distal coronary atherosclerosis was defined as a mean intimal area as a percent of medial area
of 150% over at least three coronary artery cross sections separated by 2 cm in the distal half
of the coronary artery.
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Total Internal Elastic Lamina (IEL) Area as an Assessment of Coronary
Artery Remodeling
The total area contained within the IEL has been used to assess coronary arteries for remodel-
ing during atherogenesis in humans and pigs.[5, 48, 49] Thus, the total IEL area for all three
coronary arteries from the three groups of pigs was measured as described,[23, 47] and the
results were expressed in mm2 for each of the three coronary arteries from all pigs.
Percent of Coronary Artery Cross Sections with Fibrous Caps and
Measurement of Fibrous Cap Thickness
The presence or absence of a fibrous cap was determined from visual inspection of all sections
of each coronary artery from all pigs. The results are expressed as the percent of cross sections
with fibrous caps. Maximal fibrous cap thickness was measured on the cross section with the
greatest percent stenosis for a given coronary artery and is expressed in mm.
Biostatistical Analyses
For all groups, descriptive statistics are reported as means and SD for weight, backfat, blood
pressure, triglycerides, total and LDL and HDL cholesterol, oxLDL, fructosamine, aldosterone,
inflammatory markers, insulin, glucose, Bergman Si values, coronary and aortic atherosclerosis
measurements. The coronary intimal area as a percent of medial area was used as the primary
measure of atherosclerotic severity. The Wilcoxon rank sum statistic was used as the primary
method for pairwise comparisons between severe and moderate atherosclerotic groups.
Parametric repeated measures ANCOVA models with group, time, and baseline as explanatory
factors were used as the primary method of finding association of logarithms of oxLDL, fructo-
samine, and aldosterone with atherosclerotic severity. In some of the models, atherosclerotic
severity is dichotomous. Other models manage atherosclerotic severity as continuous, using a
function of distal coronary arteries and intimal area as medial percentage. For blood pressure,
total and LDL and HDL cholesterol, and triglycerides, Wilcoxon rank sum statistics for pair-
wise comparisons between groups andWilcoxon signed ranks statistics for comparisons within
groups were used with parametric repeated measures ANCOVAmodels in mutually support-
ive ways and with comparable results. The ANCOVAmodels additionally included gender
and/or genotype as needed to account for their associations. A p-value less than 0.05 was the
criterion for identifying a change within groups, a difference between groups, or an association
of interest for future investigation.
Results
The detailed results of the atherosclerosis data are presented first followed by the metabolic
parameters that were monitored during the year long study to determine which ones were asso-
ciated with the development of either the severe and diffuse distal versus moderate coronary
atherosclerosis phenotype. Additional analyses that identified associations with p<0.05 for
gender and genotype (i.e., normocholesterolemic and FH heterozygous) are listed.
Severity of Coronary Artery Atherosclerosis
At the end of the study, 20 pigs (6 males and 14 females) fed the high fat/high NaCl diet were
found to have met the criteria for both severe and diffuse distal coronary atherosclerosis (Figs
2–4). The other 17 pigs (14 males and 3 females) also fed the same high fat/high NaCl diet had
substantially less or moderate coronary atherosclerosis. When the extent of coronary athero-
sclerosis was compared between the severe and moderate atherosclerosis groups for the
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proximal and distal halves of the coronary arteries, the severe group had much larger intimal
area, percent stenosis, and intimal area as a percent medial area (Figs 3 and 4 and Table 1,
p< 0.001). In a logistic regression model that controlled for gender, severe and diffuse coro-
nary atherosclerosis was associated with female pigs (p = 0.003). Such a model that controlled
for genotype instead of gender indicated no association of normal versus heterozygous FH
genotype with severity of atherosclerosis (p = 0.963). The 5 pigs fed regular, low fat pig chow
had little to no detectible coronary atherosclerosis (Table 1).
Coronary Artery Remodeling Assessed by Total IEL Area
The severe atherosclerosis group had substantially larger total IEL areas when compared to the
moderate (p< 0.001) or control groups (p<0.035) for all three coronary arteries (Table 2).
The data are consistent with a greater degree of positive remodeling.[5, 48, 49] Also, there was
no evidence of pairwise vessel to vessel differences in the total IEL area when comparing the
three coronary arteries within the three groups of pigs (p> 0.1) except for the right versus cir-
cumflex coronary artery comparison within the moderate atherosclerosis group (p = 0.044).
Percent of Coronary Artery Cross Sections with Fibrous Caps and
Fibrous Cap Thickness
The percent of coronary artery cross sections containing fibrous caps was much greater in the
severe and diffuse atherosclerosis group for all three coronaries (Table 2, p< 0.001). There was
no evidence among animals with detectible fibrous caps of differences between the mean
fibrous cap thicknesses for the severe and moderate groups (p> 0.1). Only one of the five con-
trol pigs had a very small fibrous cap lesion and that lesion was located in the right coronary
artery of that pig.
Fig 2. Study Outcome. The 42 pigs are described as in Fig 1 and grouped by atherosclerosis phenotype that developed during the 12-month study.
doi:10.1371/journal.pone.0132302.g002
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Fig 3. Intimal Area as %Medial Area from Serial Coronary Artery Sections. The mean ± SD for intimal
area as %medial area of all sections from all three coronary arteries are shown by severe and diffuse (black),
moderate (white), or control (grey) groups. Sections were taken at 1 cm intervals. The solid black vertical line
indicates the division between the proximal and distal halves of each coronary artery. The horizontal black
line at 200% indicates the criteria for severe coronary atherosclerosis. The hashed line at 150% indicates
diffuse and distal coronary atherosclerosis when it occurs over 3 sections (i.e., 2 cm). Using these criteria,
pigs in the severe atherosclerosis group also exhibited diffuse and distal coronary atherosclerosis in all three
coronary arteries.
doi:10.1371/journal.pone.0132302.g003
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Fig 4. Coronary Artery Atherosclerosis in Insulin Resistant Pigs. Panels A1 to A5: Representative serial sections from the proximal to distal left anterior
descending coronary artery are shown from an IR pig with severe and diffuse distal coronary atherosclerosis. The mean intimal area as a percent of medial
area for all three coronary arteries for this pig was 203.6% proximally and 338.5% distally. Panels B1 to B5: In contrast, a pig with moderate coronary
atherosclerosis had a mean intimal area as a percent of medial area for all three coronary arteries of 11.3% proximally and 5.8% distally. Features of
coronary atherosclerosis in rows A and B are shown at higher magnification in rows C and D, respectively: intimal thickening (IT) and calcification in a pig with
moderate atherosclerosis (Ca2+ (moderate), Panels B1 and D1), calcification in a pig with severe atherosclerosis (Ca2+ (severe), Panels A4 and C2), fibrous
cap (FC, Panel A2 and C1), hemorrhage into the plaque (H, Panels A4 and C3), medial thinning (MT, Panels A4 and D2), necrosis (N, Panels A4 and D3).
(Hematoxylin and Eosin, mag bar = 500 μm is shown in B5 for rows A and B; mag bar = 10 μm in all panels in rows C and D).
doi:10.1371/journal.pone.0132302.g004
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Table 1. Proximal and Distal Coronary Artery Atherosclerosis Morphometry.















Intimal area as %
medial area
Severe and Diffuse Atherosclerosis (n = 20)
Mean 6.4 7.1 57.8 142.6 3.0 5.6 68.5 210.4
± SD 1.5 3.2 18.6 69.6 1.1 2.4 21.2 90.7
Moderate Atherosclerosis (n = 17)
Mean 6.4 1.8 24.3 30.4 2.9 1.6 33.3 52.0
± SD 2.1 1.3 15.6 18.5 1.3 1.4 24.2 38.9
Control (n = 5)
Mean 4.2 0.5 6.5 12.8 1.7 0.2 3.7 10.1




0.775 < 0.001 < 0.001 < 0.001 0.478 < 0.001 < 0.001 < 0.001
Severe vs
Control
0.002 < 0.001 < 0.001 < 0.001 0.001 < 0.001 < 0.001 < 0.001
Moderate vs
Control
0.031 0.011 0.006 0.039 0.071 < 0.001 < 0.001 0.006
* Wilcoxon rank sum statistic for differences between groups.
doi:10.1371/journal.pone.0132302.t001
Table 2. Mean Coronary Artery Total IEL Area (mm2), Percent of Coronary Artery Cross Sections Containing Fibrous Caps (FC), and Fibrous Cap
Thickness (mm) in All 3 Coronary Arteries.



















Severe and Diffuse Atherosclerosis (n = 20)
Mean 10.1 81.6 0.472 9.9 88.8 0.521 9.8 83.9 0.377
± SD 2.1 16.4 0.184 3.1 24.2 0.277 2.1 17.0 0.139
Moderate Atherosclerosis (n = 17)
Mean 6.2 26.2 0.405 5.0 41.3 0.482 6.0 32.2 0.346
± SD 1.7 22.5 0.194 2.4 41.9 0.208 2.3 37.1 0.124
Control (n = 5)
Mean 6.1 1.3 0.510 6.6 0 N/A 6.4 0 N/A




< 0.001 < 0.001 0.161 < 0.001 < 0.001 0.914 < 0.001 < 0.001 0.470
Severe vs
Control
< 0.001 < 0.001 N/A 0.035 < 0.001 N/A < 0.001 < 0.001 N/A
Moderate vs
Control
1.00 < 0.001 N/A 0.164 < 0.001 N/A 0.820 < 0.001 N/A
*percent of coronary artery sections containing fibrous caps (FC),
† Wilcoxon rank sum statistic for differences between groups,
N/A is not applicable,
doi:10.1371/journal.pone.0132302.t002
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Abdominal Aortic Atherosclerosis
The 20 pigs that met the criteria for severe and diffuse distal coronary atherosclerosis had
much more abdominal aortic atherosclerosis than the 17 pigs with moderate coronary athero-
sclerosis (Table A in S1 File for intimal area and intimal area as % medial area (p 0.004) and
Table B in S1 File for en face measurement of % surface area with raised lesions, p 0.002).
The 5 control pigs had raised lesions in the abdominal aorta (range was 2.9–28.6% of total sur-
face area) that were much smaller than the other two groups (p 0.001). The intimal area as
percent medial area was also much smaller in the control pigs (Table A in S1 File, p 0.04).
Change in Fasting Glucose, Insulin, and Insulin Sensitivity by Bergman
FSIVGTT during the Year Long Study
Throughout the study, changes in fasting glucose values in conscious pigs in any group were
relatively small (Table 3 shows quarterly glucose values only, monthly values not shown). In
contrast, when the pigs were sedated for the Bergman FSIVGTT, the glucose values were
higher, possibly due to the stress of the procedure or the sedatives used. Differences between
the groups at each time point were relatively small as were change in any group over time
(p 0.05, Table 3).[50, 51]
Fasting insulin values measured during the Bergman FSIVGTT were higher at 3 (Table 4,
p< 0.001), 6 (p< 0.001), and 12 (p< 0.001) months when compared to baseline values for
the severe and diffuse coronary atherosclerosis group and at 12 months in the moderate group
(p = 0.006). The control group showed little or no evidence of change (p> 0.05, Table 4).
Analyses of fasting, 1 and 2 hour post prandial glucose and insulin levels in a subset of con-
scious pigs (n = 13 in the severe group, n = 6 in the moderate group, and n = 5 in the control
group), showed similar trends (Tables F and G in S1 File).
Table 3. Fasting Glucose Values.
Fasting Glucose (mg/dl) conscious Fasting Glucose (mg/dl) sedated
Baseline 3 month 6 month 12 month Baseline 3 month 6 month 12 month
Severe and Diffuse Atherosclerosis (n = 20)
Mean 73 78 75 77 112 125 132 136
± SD 7 11 7 6 36 34 41 39
p* 0.054 0.163 0.050 0.091 0.092 0.062
Moderate Atherosclerosis (n = 17)
Mean 75 73 76 75 114 113 114 121
± SD 7 9 6 7 23 21 29 28
p* 0.377 0.875 0.704 0.882 0.924 0.162
Control (n = 5)
Mean 76 71 69 72 137 110 117 130
± SD 5 6 6 4 25 24 22 58
p* 0.248 0.121 0.516 0.067 0.251 0.821
p†
Severe vs Moderate 0.263 0.136 0.807 0.476 0.661 0.254 0.156 0.247
Severe vs Control 0.235 0.116 0.067 0.154 0.086 0.371 0.530 0.265
Moderate vs Control 0.985 0.581 0.058 0.254 0.071 0.543 0.648 0.548
*Wilcoxon signed rank statistic for change from baseline within group.
†Wilcoxon rank sum statistic for differences between groups.
doi:10.1371/journal.pone.0132302.t003
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The decreasing mean Si values in the severe and moderate atherosclerosis groups at 3, 6 and
12 months were consistent with increased insulin resistance (p<0.001 for the severe and dif-
fuse atherosclerosis group, and p 0.005 for the moderate atherosclerosis group compared to
baseline, respectively). Likewise, the control pigs exhibited decreases in insulin sensitivity at 6
months (p = 0.033) and nearly so at 12 months (p = 0.058). There was little or no evidence of
differences in mean fasting glucose, insulin or Si values (Table 4) during the Bergman
FSIVGTT between pairs of the three groups at any timepoint (Tables 3 and 4, p> 0.05).
Change in Serum Fructosamine Levels during the Year Long Study
The log transformed serum fructosamine levels were similar at baseline for all three groups
(ANOVA, p = 0.06). Fructosamine increased substantially at 3, 6, and 12 months compared to
baseline in the group that developed severe and diffuse atherosclerosis (p 0.017), but only at
month 3 for the moderate group (Table 5, p< 0.001). There was no evidence of change in the
control pigs. The serum fructosamine level was much higher at 3, 6, and 12 months in the
severe and diffuse atherosclerosis group when compared to either the moderate atherosclerosis
or control groups (p 0.031).
Change in Weight, Backfat, and Blood Pressure during Year Long Study
The baseline, 3, 6, and 12 month weight and backfat values and blood pressure results are
shown in Tables C and D in S1 File, respectively. Weight increased substantially over time
compared to baseline in the moderate atherosclerosis group (p< 0.001) and in the severe
group (p< 0.001). There was no evidence of differences between the severe and moderate
groups for weight at study entry nor at any of the time points (p 0.4). Weight in the control
group increased moderately over time (p<0.001 at month 12, Table C in S1 File). Backfat also
Table 4. Fasting Insulin Levels and Bergman Si Values.
Fasting Insulin (μU/ml)—sedated Bergman Si
Baseline 3 month 6 month 12 month Baseline 3 month 6 month 12 month
Severe and Diffuse Atherosclerosis (n = 20)
Mean 11.8 20.4 27.2 27.2 4.1 3.9 3.7 3.6
± SD 5.3 10.0 20.0 12.5 0.3 0.3 0.4 0.4
p* < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Moderate Atherosclerosis (n = 17)
Mean 13.0 17.3 16.7 18.8 4.0 3.7 3.7 3.5
± SD 10.0 9.1 10.0 8.7 0.4 0.4 0.4 0.4
p* 0.150 0.203 0.006 0.005 < 0.001 < 0.001
Control (n = 5)
Mean 10.4 16.7 19.0 16.6 4.0 4.0 3.9 3.7
± SD 5.4 11.0 7.8 11.4 0.2 0.2 0.2 0.3
p* 0.253 0.067 0.378 1.000 0.033 0.058
p†
Severe vs Moderate 0.775 0.266 0.127 0.056 0.103 0.312 0.282 0.581
Severe vs Control 0.530 0.408 0.818 0.088 0.310 0.205 0.179 0.584
Moderate vs Control 0.880 0.581 0.401 0.842 0.555 0.211 0.287 0.198
*Wilcoxon signed rank statistic for change from baseline within group.
†Wilcoxon rank sum statistic for differences between groups.
doi:10.1371/journal.pone.0132302.t004
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increased substantially over time compared to baseline in the severe and diffuse atherosclerosis
group (p 0.003) and in the moderate atherosclerosis group (p 0.005). There was no evi-
dence of differences between the severe and moderate groups for backfat at study entry
(p = 0.265) but there was ~ 1 cm more backfat at all three time points in the severe group
(p 0.016). Back fat in the control group increased relatively minimally over time (p 0.070).
Blood pressure was in a range that would be considered mildly hypertensive in humans
(142–160 / 93–108 mmHg) with little or no evidence of interpretable differences between the
three groups (Table D in S1 File, p 0.10 for 19 of 24 cases). Blood pressure had little or no
evidence for interpretable changes over time in any group (p 0.10 for 15 of 18 cases).
Total, LDL, and HDL Cholesterol and Triglyceride Levels
The mean total cholesterol values ranged from 77 to 110 mg/dl at baseline, but it was lower for
the group that developed moderate atherosclerosis than for both the group that developed
severe and diffuse atherosclerosis and the control group (Table 6, p 0.004). A similar pattern
was seen at baseline for LDL and HDL cholesterol (Tables 6 and 7) where the mean value for
the moderate group was substantially lower than severe or control, but the control and severe
were not substantially different. Fasting triglycerides values had little to no differences between
the three groups at study entry (Table 7). For the pigs fed the high fat/high NaCl diet, fasting
total, LDL, and HDL cholesterol increased substantially at 3, 6, and 12 months relative to base-
line values within severe and moderate groups (p< 0.001), but evidence of change for triglyc-
erides was only applicable to the severe group. There were substantial differences between the
moderate and severe groups at 3, 6, and 12 months for total and LDL cholesterol and triglycer-
ides (p< 0.02), but HDL had no interpretable differences. Control pigs showed no essentially
no or minimal changes in these measurements over the 12 month study and had much lower
total cholesterol, HDL, and LDL values when compared to the pigs being fed the high fat/high
NaCl diet (p> 0.05 for all but one value).
Table 5. Fasting Fructosamine Levels (μmol/L).
Baseline 3 month 6 month 12 month
Severe and Diffuse Atherosclerosis (n = 20)
Mean 163 192 184 173
± SD 18 26 17 21
p* < 0.001 < 0.001 0.017
Moderate Atherosclerosis (n = 17)
Mean 148 171 159 150
± SD 23 24 26 23
p* < 0.001 0.111 0.818
Control (n = 5)
Mean 150 155 154 149
± SD 19 23 19 10
p* 0.221 0.058 0.961
p†
Severe vs Moderate 0.027 0.011 <0.001 0.004
Severe vs Control 0.153 0.006 0.003 0.031
Moderate vs Control 0.880 0.283 0.928 0.842
*Wilcoxon signed rank statistic for change from baseline within group.
†Wilcoxon rank sum statistic for differences between groups.
doi:10.1371/journal.pone.0132302.t005
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Table 6. Fasting Total and LDL Cholesterol.
Total cholesterol (mg/dl) LDL cholesterol (mg/dl)
Baseline 3 month 6 month 12 month Baseline 3 month 6 month 12 month
Severe and Diffuse Atherosclerosis (n = 20)
Mean 103 583 481 413 57 226 186 157
± SD 26 188 127 130 13 81 44 34
p* <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Moderate Atherosclerosis (n = 17)
Mean 77 416 366 320 44 172 143 131
± SD 20 107 163 74 14 38 50 27
p* <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Control (n = 5)
Mean 110 113 119 106 57 64 66 61
± SD 25 32 29 26 9 16 12 16
p* 0.922 0.132 0.465 0.133 0.027 0.335
p†
Severe vs Moderate 0.002 0.003 0.021 0.015 0.005 0.017 0.009 0.016
Severe vs Control 0.564 <0.001 <0.001 <0.001 0.809 <0.001 <0.001 <0.001
Moderate vs Control 0.004 <0.001 0.001 <0.001 0.056 <0.001 0.001 <0.001
*Wilcoxon signed rank statistic for change from baseline within group.
†Wilcoxon rank sum statistic for differences between groups.
doi:10.1371/journal.pone.0132302.t006
Table 7. Fasting HDL Cholesterol and Triglycerides.
HDL cholesterol (mg/dl) Triglycerides (mg/dl)
Baseline 3 month 6 month 12 month Baseline 3 month 6 month 12 month
Severe and Diffuse Atherosclerosis (n = 20)
Mean 40 81 71 65 36 47 43 52
± SD 8 29 13 15 29 28 25 39
p* <0.001 <0.001 <0.001 0.013 0.235 0.035
Moderate Atherosclerosis (n = 17)
Mean 34 82 77 78 21 25 25 21
± SD 11 28 28 19 6 12 13 11
p* <0.001 <0.001 <0.001 0.475 0.662 0.463
Control (n = 5)
Mean 44 48 48 47 29 45 45 36
± SD 6 6 8 7 12 21 30 15
p* 0.119 0.266 0.074 0.072 0.228 0.136
p†
Severe vs Moderate 0.049 0.934 0.437 0.028 0.046 0.005 0.011 0.004
Severe vs Control 0.330 0.009 <0.001 0.024 0.830 0.986 0.988 0.667
Moderate vs Control 0.025 0.006 0.048 0.001 0.182 0.032 0.240 0.020
*Wilcoxon signed rank statistic for change from baseline within group.
†Wilcoxon rank sum statistic for differences between groups.
doi:10.1371/journal.pone.0132302.t007
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Changes in Oxidized LDL
The mean oxLDL levels for the severe and diffuse atherosclerosis group at baseline, while simi-
lar to the moderate atherosclerosis group, was higher than the control group (Table 8,
p = 0.015). The values increased substantially relative to the baseline at 3, 6, and 12 months in
pigs fed the high fat/high NaCl diet (p 0.002) but not control pigs (p> 0.46). OxLDL was
substantially higher in the severe atherosclerosis group at 3, 6 and 12 months compared to the
moderate group and it was substantially lower for the control group (Table 8, p 0.002).
Changes in Aldosterone
The mean aldosterone levels were similar for all three groups at baseline (p>0.9, Table E in S1
File). The values did not increase in the control group or group with moderate coronary ath-
erosclerosis whereas in the group with severe disease there was a moderate increase above base-
line values at 6 and 12 months (p 0.042). When controlling for gender, however, the changes
in aldosterone were not associated with severe and diffuse atherosclerosis (p> 0.15). Serum
potassium and sodium levels were assayed monthly and remained within the normal range
(not shown).
Change in Inflammatory Markers during Year Long Study
The inflammatory markers (TNF-alpha, IL-6, PAI-1, CRP) did not differ between the moder-
ate and severe groups in 9 pigs with severe and diffuse coronary atherosclerosis when com-
pared to 8 pigs with moderate disease (data not shown). Since these values did not appear to be
robust markers of IR or atherosclerosis in this model, the assays were not performed in the
remaining pigs.
Table 8. Fasting oxLDL Levels (units/L).
Baseline 3 month 6 month 12 month
Severe and Diffuse Atherosclerosis (n = 20)
Mean 20.4 47.9 42.6 39.8
± SD 5.3 17.5 11.3 10.6
p* <0.001 <0.001 0.002
Moderate Atherosclerosis (n = 17)
Mean 18.7 31.5 31.3 29.8
± SD 4.8 7.1 8.2 7.0
p* <0.001 <0.001 <0.001
Control (n = 5)
Mean 13.6 12.6 14.1 13.5
± SD 4.7 3.1 4.3 3.7
p* 0.465 0.465 0.465
p†
Severe vs Moderate 0.410 <0.001 <0.001 0.002
Severe vs Control 0.015 <0.001 <0.001 <0.001
Moderate vs Control 0.088 <0.001 <0.001 <0.001
*Wilcoxon signed rank statistic for change from baseline within group.
†Wilcoxon rank sum statistic for differences between groups.
doi:10.1371/journal.pone.0132302.t008
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Adverse Events
During the year-long study, transient inappetance occurred in both the severe and diffuse (5/
20) and moderate (6/17) groups but not the control group. In general, inappetance responded
to feeding regular chow for a few days before restarting the high fat/high NaCL diet. If the pig
had hemoccult positive stools, appropriate medications were given with the advice of the
attending veterinarian (e.g., antacids and proton pump inhibitors). Two of the 6 pigs with inap-
petance in the moderate atherosclerosis group required blood transfusions for anemia due to
gastrointestinal bleeding. In all cases, sampling was not interrupted by these events. One pig in
the moderate atherosclerosis group was euthanized for persistent inappetance after 6 months
on study. One pig in the severe atherosclerosis group died suddenly at age 10 months and, in
addition to severe and diffuse coronary atherosclerosis, had a bladder infection at necropsy.
Both of these animals are included in all analyses.
Discussion
The study shows that 37 adult pigs fed a high fat/high NaCl diet exhibited a substantial increase
in IR that was accompanied by weight gain, increased backfat, and elevations in total and LDL
and HDL cholesterol levels. Those pigs that exhibited more severe as well as diffuse distal coro-
nary artery and abdominal aortic atherosclerosis had substantially greater increases in fructosa-
mine and oxLDL levels during the study compared to the pigs with moderate disease or the
control pigs. Although all animals developed increased IR during the study as reflected in the
decreasing Si values, the severity of IR was not associated with the severity of atherosclerosis.
This finding suggests that this degree of IR did not discriminate between animals that develop
severe and diffuse vs moderate atherosclerosis in this model. Since none of the IR pigs had dia-
betes, it appears that severe and diffuse atherosclerosis can develop in response to a high fat/
high NaCl diet in the absence of overt hyperglycemia but this severe atherosclerosis phenotype
is associated with increased oxLDL and fructosamine levels consistent with increased protein
glycation. These findings are also reinforced by the fact that the normal chow-fed controls also
developed IR but had no substantial change in cholesterol, oxLDL, or fructosamine levels and
little to no atherosclerosis.
Insulin Resistance
The manner in which the hyperinsulinemic state or the loss of insulin sensitivity might lead to
increased atherosclerosis remains poorly defined. Recently, several mechanisms that mediate
insulin resistance in mice, pigs, and humans have been described.[52–58] It is not yet know if
these mechanisms also mediate atherogenesis in addition to IR. Additionally the presence of IR
is often associated with hypertension, lipoprotein abnormalities, and chronic kidney disease
that further accentuate atherosclerosis risk.[59–64]
Although fully manifested diabetes mellitus in humans confers a greater risk for cardiovas-
cular disease and other complications as compared to isolated IR without hyperglycemia, the
presence of IR is a major independent risk factor with relative risk ratios between 2.2 and 2.7
when multifactorial linear regression analysis is utilized to assess risk.[2, 65, 66] Within this
broad category of insulin resistance, there are several subgroups of patients with different meta-
bolic abnormalities. Specifically some subjects have hyperlipidemia without overt diabetes,
some have diabetes without hyperlipidemia, and both groups can have abnormalities in glucose
dynamics and elevated levels of oxidized LDL as well as other glycated proteins such as
HgbA1c and fructosamine.
Our IR pigs had elevated glucose levels during the Bergman FSIVGTT when sedated but not
when fully conscious (Table 3). It is possible that the sedatives used in these pigs contributed to
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the glucose elevations (i.e., acepromazine and ketamine). Isoflurane has been shown to alter
insulin sensitivity in pigs, possibly from direct drug effects as well as procedure-related stress.
[50, 51] Importantly, since all Si measurements were done with sedation, the observed reduc-
tion in Si over 12 months is interpretable and was clearly progressive. Despite this increase in
insulin resistance, however, there was no detectible association between the degree of changes
in insulin sensitivity and the severity of atherosclerosis in the pigs in this study.
Cholesterol Levels and Atherosclerosis Severity
All pigs fed the high fat/high NaCl diet exhibited hypercholesterolemia but the levels were
higher in pigs that developed severe and diffuse atherosclerosis. This difference in total and
LDL cholesterol levels accounts for some, but not all, of the observed differences between
groups according to atherosclerosis severity. In mixed models that used a continuous measure
of coronary artery atherosclerosis severity, controlling for gender, baseline values, and varia-
tions in total cholesterol over time, there are still substantial strengths of association between
coronary artery atherosclerosis severity and oxLDL (p = 0.035) and fructosamine (p = 0.022)
that are independent of the changes in total or LDL cholesterol. Such models also indicated an
association between the variation of total cholesterol over time with fructosamine (p< 0.001)
and oxLDL (p< 0.001). Thus, while there are associations of cholesterol levels and atheroscle-
rosis severity, the more noteworthy issue for cholesterol was the extent to which it fully or
partly explained the associations of atherosclerosis severity with increased levels of fructosa-
mine and oxLDL.
Fructosamine
Fructosamine is used as an index of mean blood glucose and is predictive of incident diabetes
and microvascular complications in humans.[67] In pigs, fructosamine is also a reliable and
important marker of mean blood glucose since pig red blood cells are relatively impermeable to
glucose and thus hemoglobin A1c is not a reliable index of mean glucose concentrations in this
species.[16, 68] Fructosamine is also a measure of protein glycation.[69] In our study, the fruc-
tosamine levels measured during the fasting state rose relative to baseline values in the group of
animals that developed severe and diffuse coronary atherosclerosis but the levels were not ele-
vated to a point that they would reflect meaningful and/or sustained hyperglycemia.
With regards to blood glucose levels, studies in humans have shown that stress-induced
hyperglycemia correlates with subsequent development of diabetes and that the subjects who
were predisposed to develop glucose intolerance during the FSIVGTT had higher fructosamine
levels at baseline.[70] As mentioned above, the IR pigs appeared to exhibit stress-associated
hyperglycemia during the Bergman FSIVGTT that may have accounted for some portion of
the higher fructosamine levels. Fructosamine has also been shown to correlate with 2 hr post-
prandial glucose[71] and relatively short periods of hyperglycemia have been shown to increase
protein glycation even if fasting glucose is not increased.[72] Presumably the increase in fructo-
samine in the IR pigs with severe and diffuse atherosclerosis reflects a modest increase in mean
daily glucose levels, although periods of post prandial hyperglycemia of short duration followed
by periods of normoglycemia as the sole cause cannot be excluded. Regardless of the cause, the
degree of fructosamine increase was substantially greater in pigs with severe and diffuse athero-
sclerosis than the change that occurred in the group with moderate atherosclerosis or the con-
trol group. Therefore, it is possible that even a relatively modest change in fructosamine
reflects a contribution of increased mean glucose values that would contribute to increased pro-
tein glycation and atherosclerosis development.
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With regards to atherosclerosis, most reports have compared the degree of fructosamine
change that occurs with impaired glucose tolerance to subjects with normal glucose tolerance
and correlated this with a change in atherosclerotic risk. Studies in experimental animal models
have reported increases in fructosamine over the range noted in our animals as being associ-
ated with biochemical changes that are believed to predispose to increase risk of atherosclerosis
and some studies in humans with impaired glucose tolerance have demonstrated an increase in
carotid intimal media thickening.[73] Although studies in which fructosamine changes alone,
independent of changes in lipoproteins, predispose to increased coronary and aortic athero-
sclerosis have not been reported, there are studies wherein changes in advanced glycation end
products or glycated albumin (another surrogate measurement of serum glycated protein con-
centrations) have been shown to predict atherosclerosis risk.[74–77] When measures of
advanced glycation end products other than fructosamine or glycated albumin are utilized,
there are also strong associations with the presence of advanced atherosclerosis.[78–80] Impor-
tantly, in a prospective study in adult humans without diabetes, higher HgbA1c was indepen-
dently associated with progression of advanced coronary artery calcification.[81] Therefore,
the combination of abnormal blood glucose dynamics that are not classified as overt diabetes
and elevated concentrations of glycated proteins is associated with the development of
advanced coronary atherosclerosis in humans and pigs.
Oxidized LDL (oxLDL)
Increases in oxidized LDL in humans, pigs, and rodents are associated with increased athero-
sclerosis and reduction in oxLDL is associated with reduced atherosclerosis.[82–87] The mech-
anism by which these changes in oxLDL might modulate atherosclerosis severity cannot be
completely separated from the changes induced by protein glycation since exposure of LDL to
high glucose concentrations results in abnormal glycation as well as oxidation.[88] In humans,
increased glycemic index is also associated with increased oxLDL when total LDL remains
unchanged.[82, 89–91] The more modest increase in postprandial glucoses in subjects with
impaired glucose tolerance can also lead to elevated oxLDL[92–95] and treatment of those sub-
jects lowers oxLDL.[96–99] Also, reductions in fat mass, dietary fat, and blood glucose have
been shown to be associated with decreases in oxLDL.[100–103] A few studies have reported
increases in oxLDL in nondiabetic subjects with impaired glucose tolerance[104–106] and one
reported a positive correlation between oxLDL in normal subjects who also exhibited higher
fructosamine levels.[104] Moreover, even small increases in postprandial glucose that are
within the normal range can lead to increases in oxidized LDL[82, 107] and small reductions in
postprandial glucose in patients with type 2 diabetes also lead to decreased oxidized LDL.[82,
107] Since oxidized LDL was increased in the pigs that developed severe and diffuse atheroscle-
rosis, it is possible that increases solely in their postprandial glucoses were sufficient to contrib-
ute to the elevation in oxLDL levels.
Atherosclerosis Morphology in Insulin Resistance
Coronary artery atherosclerosis in the IR pigs showed fibrous cap formation, foam cells, medial
thinning, plaque hemorrhage, necrosis, and calcification (Fig 4). All of these characteristics
have been described in atherosclerotic plaques from IR and diabetic humans.[5, 7] Similar his-
tological findings have been described in pigs given streptozotocin and fed a high fat diet.[16]
An important characteristic is the presence of distal coronary atherosclerosis which has been a
consistent finding in asymptomatic IR and diabetic patients screened by electron beam com-
puted tomography and magnetic resonance imaging,[4, 8] clinically symptomatic IR patients
by quantitative angiography[6] and in type 2 diabetic patients who died suddenly.[5] Thick
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fibrous caps (>64 μm) are more common in coronary atherosclerotic plaques of humans with
type 2 diabetes who died suddenly.[5] In our study, the fibrous caps were more abundant in
pigs with severe atherosclerosis than those with moderate atherosclerosis (Table 2).
Clinical studies have reported an increase in coronary artery remodeling in diabetic victims
of sudden death.[5] The mean total IEL areas for serial sections in all 3 coronary arteries from
IR pigs with severe atherosclerosis was larger than those with moderate atherosclerosis
(Table 2). This finding is consistent with positive remodeling.[5, 48, 49] Thus, the coronary
atherosclerotic plaques in the IR pigs with severe and diffuse disease also exhibited many of the
phenotypic characteristics that are found in IR humans.
Gender
Severe and diffuse atherosclerosis occurred more commonly in IR female pigs fed the high fat/
high NaCl diet. One study conducted in nondiabetic female minipigs designed to develop met-
abolic syndrome found they became more insulin resistant and developed more atherogenic
lipoprotein changes compared to males.[108] In insulin resistant humans, incident cardiovas-
cular disease is more prevalent in women from many different ethnic groups including Cauca-
sians, Latinos, American Indians, and several European populations.[109] Additionally
increased levels of glycated proteins predicted mortality from coronary heart disease in non-
diabetic women but not non-diabetic men.[74] The reason for this difference between genders
is unknown. It is speculated that the difference may in part be explained by a higher burden of
all risk factors for cardiovascular disease and a greater effect of high blood pressure and athero-
genic dyslipidemia in women when compared to men.[110]
Mechanism of glycation induced changes in atherosclerosis severity
Although our study was not designed to identify or measure the mechanism by which changes
in oxLDL or glycated proteins would induce atherogenesis, the cell surface receptor RAGE is
thought to be a key mediator.[111] RAGE is induced in blood vessels under these conditions
and the soluble form of RAGE that is secreted is increased in patients with severe atherosclero-
sis and abnormal protein glycation. The mechanism by which these combinations of metabolic
changes induce atherosclerosis has been proposed to be activation of macrophages that in turn
further oxidize LDL. An additional proposed mechanism is the inhibition of autophagy. Specif-
ically glycated albumin results in autophagy dysfunction in pancreatic beta cells leading to
enhanced pancreatic cell death.[112] A reduction in the rate of autophagy induced by glycated
proteins has also been implicated in pericyte dropout and the subsequent development of dia-
betic retinopathy.[113] Finally inhibition of autophagy has been shown to be important for
mediating changes in endothelial cells that have been associated with atherosclerosis.[114] The
results of our study support the hypothesis that elevations in glycated proteins in IR pigs could
lead to more severe and diffuse atherosclerosis at least in part through inhibition of autophagy.
Study Limitations
We chose to measure parameters that have been associated with increased atherosclerosis and
insulin resistance in humans: blood pressure, body weight, body fat, hyperlipidemia, inflamma-
tory markers, glycated proteins including fructosamine and oxLDL, and aldosterone. This
study design addressed the extent to which each of these parameters, as measured at 4 time
points, were associated with the severity of atherosclerosis that developed in pigs with compa-
rable IR. The grouping of pigs by atherosclerosis severity was only possible after feeding the
high fat diet for one year. As the investigators did not know which pigs had severe atherosclero-
sis until the end of the study, one can regard the investigators as being blinded. Likewise,
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evaluating these parameters for association with atherosclerosis severity could only be done
after identifying the groups according to specific criteria that were defined a priori. Although
possibly introducing some bias, this grouping is comparable to a ranking that classified some-
what more than half as severe and the others as moderate. We have additionally addressed this
possibility by analyzing changes over time with appropriate and validated statistical methods.
[115] We may have inadvertently omitted other parameters that could be associated with ath-
erosclerosis severity that could also be analyzed in a similar fashion. We did not measure gly-
cated proteins in tissues so we do not know the extent to which such measurements would or
would not have correlated with the fructosamine and oxLDL levels measured in the circulation.
The other limitation of our study is that it is purely hypothesis generating, and not hypothesis
testing, as many pairwise comparisons were made.
Conclusion
Our goal was to develop a useful animal model of insulin resistance that also develops coronary
artery and aortic atherosclerosis. Several investigators have used pigs to study the impact of
diabetes on atherogenesis, most of whom have used chemical induction of insulin-deficiency.
[16, 18, 116, 117] In contrast, we used pigs that developed increased insulin resistance in asso-
ciation with weight gain, increased backfat, increased total and LDL and HDL cholesterol lev-
els, and elevated blood pressure. Our model has some features of the metabolic syndrome and
about half of the animals developed more severe and diffuse atherosclerosis. The metabolic var-
iables that are associated with atherosclerosis severity are increases in fructosamine and oxi-
dized LDL. Our study had a robust number of pigs and it would be reasonable expect to see a
similar effect size in future studies. This animal model should be useful for identifying and
studying mechanisms of disease that are suggested by these associations and for testing new
therapeutic approaches designed to reduce or prevent the development of severe and diffuse
atherosclerosis in insulin resistant subjects. Our data provide a rational basis for determining
the number of animals required for such a mechanistic-based study to detect significant differ-
ences between treatment groups.
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